Aquinox Pharmaceuticals announces closing of
IPO
13/03/2014 13:34
Aquinox Pharmaceuticals, Inc. announced the closing of its initial public offering of 4,830,000 shares of its common stock at a public offering price of USD 11, which included 630,000 shares issued upon the exercise in full of the underwriters' option to purchase additional shares. All of the shares of common stock were offered by Aquinox. The aggregate offering price was USD 53.1 million, before underwriting discounts, commissions and estimated expenses. The net proceeds from the sale of the shares, after deducting the underwriting discounts, commissions and other estimated offering expenses, will be approximately USD 47 million. Jefferies LLC and Cowen and Company acted as joint book-running managers and Canaccord Genuity acted as co-manager for the offering.
13/03/2014 13:34
Aquinox Pharmaceuticals, Inc. announced the closing of its initial public offering of 4,830,000 shares of its common stock at a public offering price of USD 11, which included 630,000 shares issued upon the exercise in full of the underwriters' option to purchase additional shares. All of the shares of common stock were offered by Aquinox. The aggregate offering price was USD 53.1 million, before underwriting discounts, commissions and estimated expenses. The net proceeds from the sale of the shares, after deducting the underwriting discounts, commissions and other estimated offering expenses, will be approximately USD 47 million. Jefferies LLC and Cowen and Company acted as joint book-running managers and Canaccord Genuity acted as co-manager for the offering.
